The South Korea Periodontal Disease Treatment Market was valued at $26.18 Million in 2024 and projected to reach to $35.88 Million by 2029, representing a compound annual growth rate of 5.4%. South Korea's periodontal disease treatment market is poised for sustained growth through 2029, supported by the nation's robust healthcare system and population's strong emphasis on oral health maintenance.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea's periodontal disease treatment market is valued at USD 26.18 million in 2024, with projected growth to USD 35.88 million by 2029, demonstrating a steady 5.4% CAGR driven by increasing dental health awareness.
South Korea's state-of-the-art dental facilities and high adoption of digital periodontal technologies position the country as a leader in innovative treatment solutions within the Asia-Pacific region.
South Korean consumers demonstrate exceptional dental health consciousness, with strong preventive care practices and willingness to invest in professional periodontal treatments, supporting consistent market expansion.
Rising prevalence of periodontal diseases among South Korea's aging population and increased accessibility to specialized periodontal clinics are key drivers of market growth through 2029.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | AGGRESSIVE PERIODONTITIS (Disease) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5.9% from 2024 to 2029 |
| Largest Segment | NON-SURGICAL TREATMENT (Treatment) |
| Market Size Base Year (Billions) | ~USD 2.57 (2024) |
| Revenue Forecast (Billions) | ~USD 3.43 (2029) |
| Segments Covered | Product, Disease, Type, Treatment |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| DENTSPLY SIRONA | United States | Public Company | Connected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions, |
| ENVISTA HOLDINGS CORPORATION | United States | Public Company | Specialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization, |
| HENRY SCHEIN, INC. | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BIOLASE, INC. | United States | Public Company | Waterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces, |
| NAKANISHI INC. | Japan | Public Company | Dental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products, |
| A-DEC INC. | Switzerland | Public Company | Flexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting, |
DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.
ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.
HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.
BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.
NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.
A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.
South Korea's periodontal disease treatment market was valued at USD 26.18 million in 2024.
South Korea's periodontal disease treatment market is projected to reach USD 35.88 million by 2029.
South Korea's periodontal disease treatment market is expected to grow at a CAGR of 5.4% from 2024 to 2029.
South Korea's market growth is driven by an aging population, high dental care awareness, advanced healthcare infrastructure, and increasing adoption of minimally invasive treatment technologies.
South Korea maintains a mature and well-developed periodontal disease treatment market within the Asia Pacific region, supported by strong healthcare infrastructure and high patient awareness.
Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report